Tumor Biology (Oct 2017)

Glycoprotein CA19.9-specific monoclonal antibodies recognize sialic acid–independent glycotope

  • Manoj Chugh,
  • Vladimir Piskarev,
  • Oxana Galanina,
  • Nailya Khasbiullina,
  • Pallavi Kadam,
  • Nadezhda Shilova,
  • Galina Pazynina,
  • Kira Dobrochaeva,
  • Paresh Bhanushali,
  • Nikolay Kozlov,
  • Nikolay Tupitsin,
  • Nicolai Bovin

DOI
https://doi.org/10.1177/1010428317725434
Journal volume & issue
Vol. 39

Abstract

Read online

A repertoire of monoclonal antibodies was generated by immunization of mice with cancer-associated glycoprotein CA19.9, and two of them were selected as optimal capture and detecting counterparts for sandwich test system for detection of CA19.9. Fine epitope specificity of the antibodies was determined using printed glycan array, enzyme-linked immunosorbent assay, and inhibitory enzyme-linked immunosorbent assay. Unexpectedly, both immunoglobulins did not bind key epitope of CA19.9 glycoprotein, tetrasaccharide SiaLe A , as well as its defucosylated form sialyl Le C (known as CA-50 epitope). The antibodies were found to have different glycan-binding profiles; however, they recognized similar glycotopes with common motif Galβ1-3GlcNAcβ (Le C ), thus resembling specificity of human natural cancer-associated anti-Le C antibodies. We propose that cancer-specific glycopeptide epitope includes Galβ1-3GlcNAcβ fragment of a glycoprotein O-chain in combination with proximal hydrophobic amino acid(s) of the polypeptide chain.